New Delhi, July 14, 2022 (GLOBE NEWSWIRE) — A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global minimally invasive surgical instruments market was worth USD 21.7 billion in the year 2020. The market is estimated to grow at a CAGR of 7.6%, earning revenue of around USD 36.0 billion by the end of 2027. The increasing demand for minimally invasive surgical instruments is propelled by the rising prevalence of various chronic and lifestyle diseases and patients’ growing preference for minimally invasive surgeries. Furthermore, the surging geriatric population is also a crucial factor for the growth of the overall market. However, the shortage of skilled surgeons in emerging economies may hamper the growth of the global minimally invasive surgical instruments market in the long run.
Collaborative Efforts by Industry Players Is Estimated to The Drive the Growth of The Global Minimally Invasive Surgical Instruments Market
A number of leading industry players are announcing their collaborations with other companies and research institutes to develop minimally invasive surgical instruments. As robotics becomes more feasible in laparoscopic surgeries, changes are expected to occur in the medical industry in the foreseeable future. For instance, medical device and technology company Lazurite Holdings LLC recently announced its collaboration with The Centre of Health Affairs and its business affiliate…
